Silence Therapeutics (SLN) Short-Term Debt repayments (2020 - 2024)
Historic Short-Term Debt repayments for Silence Therapeutics (SLN) over the last 5 years, with Q3 2024 value amounting to -$63665.7.
- Silence Therapeutics' Short-Term Debt repayments fell 257.49% to -$63665.7 in Q3 2024 from the same period last year, while for Sep 2024 it was -$226624.1, marking a year-over-year decrease of 2545.86%. This contributed to the annual value of -$516226.7 for FY2020, which is N/A changed from last year.
- As of Q3 2024, Silence Therapeutics' Short-Term Debt repayments stood at -$63665.7, which was down 257.49% from -$62067.6 recorded in Q3 2023.
- Over the past 5 years, Silence Therapeutics' Short-Term Debt repayments peaked at $559704.9 during Q3 2021, and registered a low of -$701659.6 during Q2 2021.
- In the last 5 years, Silence Therapeutics' Short-Term Debt repayments had a median value of -$62965.7 in 2022 and averaged -$76467.7.
- Per our database at Business Quant, Silence Therapeutics' Short-Term Debt repayments soared by 9102.62% in 2022 and then plummeted by 25109.61% in 2023.
- Silence Therapeutics' Short-Term Debt repayments (Quarter) stood at -$171658.6 in 2020, then surged by 426.06% to $559704.9 in 2021, then tumbled by 103.16% to -$17678.2 in 2022, then crashed by 251.1% to -$62067.6 in 2023, then fell by 2.57% to -$63665.7 in 2024.
- Its Short-Term Debt repayments stands at -$63665.7 for Q3 2024, versus -$62067.6 for Q3 2023 and -$42546.3 for Q2 2023.